Search - tctmd.com

Displaying 1 - 20 of 100

Sort: Relevancy | Date

Presentation TCT 2025

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Presentation TCT 2025

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Presenter: Ulf Teichgräber

October 26, 2025

Presentation TCT 2025

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Presenter: Osamu Iida

October 26, 2025

Presentation TCT 2025

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

Presenter: Seung-Whan Lee

October 26, 2025

Presentation TCT 2025

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

Presenter: Yuki Sakamoto

October 26, 2025

Presentation TCT 2025

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

Presenter: YUKI SHIMA

October 26, 2025

Presentation TCT 2025

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

Presenter: Jonghu Shin

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Presenter: Ramon L. Varcoe

October 26, 2025

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Presentation TCT 2024

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Presenter: Seung-Jun Lee

October 28, 2024

Presentation TCT 2024

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

Presenter: Jae Young Jeung

October 28, 2024

Presentation TCT 2024

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

Presentation TCT 2023

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

Presenter: Kazuki Tobita

October 25, 2023

Presentation TCT 2023

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

Presenter: Donna Lin

October 25, 2023

Presentation TCT 2023

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Presenter: Marco Ferrone

October 24, 2023

Presentation TCT 2023

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

Presenter: Ajanta De

October 24, 2023

Presentation TCT 2022

TCT 209: Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study

Presenter: Sahil Parikh

September 17, 2022

Advertisement

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

TCT 209: Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content